USA Pharmaceutical Contract Manufacture Organization Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Pharmaceutical Contract Manufacture Organization market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Pharmaceutical Contract Manufacture Organization market. Detailed analysis of key players, along with key growth strategies adopted by Pharmaceutical Contract Manufacture Organization industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Aenova Group

    • Famar SA

    • Baxter Biopharma Solutions (Baxter International Inc)

    • Recipharm AB

    • Catalent Inc

    • Thermo Fisher Scientific Inc (Patheon Inc)

    • Pfizer CentreSource (Pfizer Inc)

    • Jubilant Life Sciences Ltd

    • Boehringer Ingelheim Group

    • Lonza Group AG

    By Type:

    • Active Pharmaceutical Ingredients (APIs)

    • Finished Dose Formulations (FDFs)

    By End-User:

    • Specialty/Midsize

    • Generics

    • Big Pharma

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Pharmaceutical Contract Manufacture Organization Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Active Pharmaceutical Ingredients (APIs) from 2016 to 2027

      • 1.3.2 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Finished Dose Formulations (FDFs) from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Specialty/Midsize from 2016 to 2027

      • 1.4.2 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Generics from 2016 to 2027

      • 1.4.3 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Big Pharma from 2016 to 2027

      • 1.4.4 USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Pharmaceutical Contract Manufacture Organization Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Pharmaceutical Contract Manufacture Organization by Major Types

      • 3.4.1 Market Size and Growth Rate of Active Pharmaceutical Ingredients (APIs)

      • 3.4.2 Market Size and Growth Rate of Finished Dose Formulations (FDFs)

    4 Segmentation of Pharmaceutical Contract Manufacture Organization Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Pharmaceutical Contract Manufacture Organization by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pharmaceutical Contract Manufacture Organization in Specialty/Midsize

      • 4.4.2 Market Size and Growth Rate of Pharmaceutical Contract Manufacture Organization in Generics

      • 4.4.3 Market Size and Growth Rate of Pharmaceutical Contract Manufacture Organization in Big Pharma

      • 4.4.4 Market Size and Growth Rate of Pharmaceutical Contract Manufacture Organization in Other

    5 Market Analysis by Regions

    • 5.1 USA Pharmaceutical Contract Manufacture Organization Production Analysis by Regions

    • 5.2 USA Pharmaceutical Contract Manufacture Organization Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis

    • 6.1 West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major Types

    • 6.2 West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major End-Users

    7 South USA Pharmaceutical Contract Manufacture Organization Landscape Analysis

    • 7.1 South USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major Types

    • 7.2 South USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major End-Users

    8 Middle West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis

    • 8.1 Middle West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major Types

    • 8.2 Middle West USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major End-Users

    9 Northeast USA Pharmaceutical Contract Manufacture Organization Landscape Analysis

    • 9.1 Northeast USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major Types

    • 9.2 Northeast USA Pharmaceutical Contract Manufacture Organization Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Aenova Group

        • 10.1.1 Aenova Group Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Famar SA

        • 10.2.1 Famar SA Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Baxter Biopharma Solutions (Baxter International Inc)

        • 10.3.1 Baxter Biopharma Solutions (Baxter International Inc) Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Recipharm AB

        • 10.4.1 Recipharm AB Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Catalent Inc

        • 10.5.1 Catalent Inc Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Thermo Fisher Scientific Inc (Patheon Inc)

        • 10.6.1 Thermo Fisher Scientific Inc (Patheon Inc) Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Pfizer CentreSource (Pfizer Inc)

        • 10.7.1 Pfizer CentreSource (Pfizer Inc) Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Jubilant Life Sciences Ltd

        • 10.8.1 Jubilant Life Sciences Ltd Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Boehringer Ingelheim Group

        • 10.9.1 Boehringer Ingelheim Group Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Lonza Group AG

        • 10.10.1 Lonza Group AG Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Active Pharmaceutical Ingredients (APIs) from 2016 to 2027

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Finished Dose Formulations (FDFs) from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Specialty/Midsize from 2016 to 2027

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Generics from 2016 to 2027

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Big Pharma from 2016 to 2027

    • Figure USA Pharmaceutical Contract Manufacture Organization Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Pharmaceutical Contract Manufacture Organization Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Pharmaceutical Contract Manufacture Organization

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Pharmaceutical Contract Manufacture Organization by Different Types from 2016 to 2027

    • Table Consumption Share of Pharmaceutical Contract Manufacture Organization by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Active Pharmaceutical Ingredients (APIs)

    • Figure Market Size and Growth Rate of Finished Dose Formulations (FDFs)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Pharmaceutical Contract Manufacture Organization by Different End-Users from 2016 to 2027

    • Table Consumption Share of Pharmaceutical Contract Manufacture Organization by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Specialty/Midsize

    • Figure Market Size and Growth Rate of Generics

    • Figure Market Size and Growth Rate of Big Pharma

    • Figure Market Size and Growth Rate of Other

    • Table USA Pharmaceutical Contract Manufacture Organization Production by Regions

    • Table USA Pharmaceutical Contract Manufacture Organization Production Share by Regions

    • Figure USA Pharmaceutical Contract Manufacture Organization Production Share by Regions in 2016

    • Figure USA Pharmaceutical Contract Manufacture Organization Production Share by Regions in 2021

    • Figure USA Pharmaceutical Contract Manufacture Organization Production Share by Regions in 2027

    • Table USA Pharmaceutical Contract Manufacture Organization Consumption by Regions

    • Table USA Pharmaceutical Contract Manufacture Organization Consumption Share by Regions

    • Figure USA Pharmaceutical Contract Manufacture Organization Consumption Share by Regions in 2016

    • Figure USA Pharmaceutical Contract Manufacture Organization Consumption Share by Regions in 2021

    • Figure USA Pharmaceutical Contract Manufacture Organization Consumption Share by Regions in 2027

    • Table West USA Pharmaceutical Contract Manufacture Organization Consumption by Types from 2016 to 2027

    • Table West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types from 2016 to 2027

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2016

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2021

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2027

    • Table West USA Pharmaceutical Contract Manufacture Organization Consumption by End-Users from 2016 to 2027

    • Table West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2016

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2021

    • Figure West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2027

    • Table South USA Pharmaceutical Contract Manufacture Organization Consumption by Types from 2016 to 2027

    • Table South USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types from 2016 to 2027

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2016

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2021

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2027

    • Table South USA Pharmaceutical Contract Manufacture Organization Consumption by End-Users from 2016 to 2027

    • Table South USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2016

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2021

    • Figure South USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2027

    • Table Middle West USA Pharmaceutical Contract Manufacture Organization Consumption by Types from 2016 to 2027

    • Table Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2016

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2021

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2027

    • Table Middle West USA Pharmaceutical Contract Manufacture Organization Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2016

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2021

    • Figure Middle West USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2027

    • Table Northeast USA Pharmaceutical Contract Manufacture Organization Consumption by Types from 2016 to 2027

    • Table Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2016

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2021

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by Types in 2027

    • Table Northeast USA Pharmaceutical Contract Manufacture Organization Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2016

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2021

    • Figure Northeast USA Pharmaceutical Contract Manufacture Organization Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Aenova Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aenova Group

    • Figure Sales and Growth Rate Analysis of Aenova Group

    • Figure Revenue and Market Share Analysis of Aenova Group

    • Table Product and Service Introduction of Aenova Group

    • Table Company Profile and Development Status of Famar SA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Famar SA

    • Figure Sales and Growth Rate Analysis of Famar SA

    • Figure Revenue and Market Share Analysis of Famar SA

    • Table Product and Service Introduction of Famar SA

    • Table Company Profile and Development Status of Baxter Biopharma Solutions (Baxter International Inc)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter Biopharma Solutions (Baxter International Inc)

    • Figure Sales and Growth Rate Analysis of Baxter Biopharma Solutions (Baxter International Inc)

    • Figure Revenue and Market Share Analysis of Baxter Biopharma Solutions (Baxter International Inc)

    • Table Product and Service Introduction of Baxter Biopharma Solutions (Baxter International Inc)

    • Table Company Profile and Development Status of Recipharm AB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Recipharm AB

    • Figure Sales and Growth Rate Analysis of Recipharm AB

    • Figure Revenue and Market Share Analysis of Recipharm AB

    • Table Product and Service Introduction of Recipharm AB

    • Table Company Profile and Development Status of Catalent Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Catalent Inc

    • Figure Sales and Growth Rate Analysis of Catalent Inc

    • Figure Revenue and Market Share Analysis of Catalent Inc

    • Table Product and Service Introduction of Catalent Inc

    • Table Company Profile and Development Status of Thermo Fisher Scientific Inc (Patheon Inc)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific Inc (Patheon Inc)

    • Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific Inc (Patheon Inc)

    • Figure Revenue and Market Share Analysis of Thermo Fisher Scientific Inc (Patheon Inc)

    • Table Product and Service Introduction of Thermo Fisher Scientific Inc (Patheon Inc)

    • Table Company Profile and Development Status of Pfizer CentreSource (Pfizer Inc)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer CentreSource (Pfizer Inc)

    • Figure Sales and Growth Rate Analysis of Pfizer CentreSource (Pfizer Inc)

    • Figure Revenue and Market Share Analysis of Pfizer CentreSource (Pfizer Inc)

    • Table Product and Service Introduction of Pfizer CentreSource (Pfizer Inc)

    • Table Company Profile and Development Status of Jubilant Life Sciences Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jubilant Life Sciences Ltd

    • Figure Sales and Growth Rate Analysis of Jubilant Life Sciences Ltd

    • Figure Revenue and Market Share Analysis of Jubilant Life Sciences Ltd

    • Table Product and Service Introduction of Jubilant Life Sciences Ltd

    • Table Company Profile and Development Status of Boehringer Ingelheim Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Boehringer Ingelheim Group

    • Figure Sales and Growth Rate Analysis of Boehringer Ingelheim Group

    • Figure Revenue and Market Share Analysis of Boehringer Ingelheim Group

    • Table Product and Service Introduction of Boehringer Ingelheim Group

    • Table Company Profile and Development Status of Lonza Group AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Lonza Group AG

    • Figure Sales and Growth Rate Analysis of Lonza Group AG

    • Figure Revenue and Market Share Analysis of Lonza Group AG

    • Table Product and Service Introduction of Lonza Group AG


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.